Compounded GLP-1 medications require refrigeration
Express Scripts requires BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
Disulfide Bridge Configuration The integrity of the disulfide bond within Cagrilintides structure plays a pivotal role in preserving its tertiary conformation
Importantly, support for mental health for patients with obesity receiving a GLP-1 based therapy should integrate conversations with the patient about obesity as a chronic disease and include discussion on changes in body image, changes in relationships, including with family, friends and the environment, and unrealistic expectations of treatment
There were about 3.8 million GLP-1 prescriptions covered by Medicaid in 2023, compared to 755,000 in 2019, results show
A deeper understanding of the mechanisms of action of small molecules, the exact sites of action, the necessary dose to achieve the desired effect, and the optimal time to start antioxidant therapy for preventive or curative effects may provide a rational approach that may result in greater pharmacological and clinical success in low-molecular-weight antioxidant therapy
